Navco Pharmaceuticals Inc (NAV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2022 | 06-2021 | 06-2020 | 06-2019 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2 | 12 | 181 | 204 | 23 |
| Receivables | 110 | 104 | 0 | 25 | 73 |
| TOTAL | $112 | $116 | $181 | $231 | $100 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $112 | $116 | $181 | $231 | $100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 61 | 11 | 14 | 12 | 0 |
| Accrued Expenses | 48 | 8 | 7 | 9 | 0 |
| TOTAL | $109 | $19 | $20 | $21 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $109 | $19 | $20 | $21 | $0 |
| Shareholders' Equity | |||||
| Common Shares | 316 | 316 | 294 | 294 | 100 |
| Retained earnings | -402 | -308 | -234 | -185 | 0 |
| Other shareholders' equity | 90 | 90 | 101 | 101 | 0 |
| TOTAL | $3 | $97 | $161 | $211 | $100 |
| Total Liabilities And Equity | $112 | $116 | $181 | $231 | $100 |